All News

More intense surveillance and treatment in the first 2 years after a bladder cancer diagnosis could reduce the number of patients whose cancer recurs and lower the death rate from this disease, according to researchers from UCLA’s Jonsson Comprehensive Cancer Center.

Learning the skills required to execute basic laparoscopic sutures need not be a time-consuming, tedious exercise. Basic moves and skills can be acquired in as little as 3 hours, say researchers from the Ohio State University Medical Center, Columbus.

Findings from a 15-year retrospective chart review of men treated for recalcitrant post-prostatectomy bladder neck contracture and incontinence offer insight for urologists on expected outcomes for this challenging patient population.

Hitting all the highlights of an event as large as the AUA annual meeting is nearly impossible. But since returning home from San Diego, three topics have stuck with me as especially relevant.

Men using long-term, high-dose prescription opioids for back pain were about 50% more likely to be using medications for erectile dysfunction than men with back pain who were not using opioids, researchers reported.

Consumption of sugar-sweetened soda and punch is associated with an elevated risk of kidney stone formation, according to a recent study.

Intensity-modulated radiation therapy may not be more effective than conformal radiation therapy in patients who have undergone radical prostatectomy, say researchers from the University of North Carolina, Chapel Hill.

Surveillance for cancer recurrence, rather than additional chemotherapy or radiation therapy, is sufficient for the vast majority of men who have undergone successful surgery for stage I seminoma, a long-term study suggests.

The effect of percutaneous tibial nerve stimulation in patients with overactive bladder appears to be durable at up to 3 years, a recently published study demonstrates.

Data from a third planned interim analysis of a phase III trial are consistent with earlier results supporting the efficacy and safety of abiraterone acetate (Zytiga) as a treatment for chemotherapy-naïve men with metastatic castration-resistant prostate cancer.

Three urologists discuss how they review prostate cancer treatment options with their patients.

The new-generation GreenLight XPS-180W laser system (American Medical Systems, Minnetonka, MN) achieved an improved rate of tissue vaporization and overall efficacy in patients with BPH compared to an earlier generation laser, according to results of a recent multicenter study.

Urethral stricture is a morbid disorder for many patients, and old age and greater stricture length are associated with a particularly high risk of complications, Canadian researchers report.

Despite their apparent complexity, trusts can be extremely useful in many aspects of planning your estate.

Robot-assisted laparoscopic prostatectomy in patients with intermediate- or high-risk cancers achieves outcomes similar to those seen with the open procedure, say researchers from Vanderbilt University, Nashville, TN.

In this case, the woman claimed her damages from the negligent nerve injury included pain and weakness in her legs and a second operation to replace the sling.

The way medical necessity is currently being reviewed and judged is cause for concern.

The clinical advantages of adjuvant or salvage radiation therapy in patients treated for prostate cancer by radical prostatectomy is currently a much-debated issue and is frequently decided for the individual patient. New evidence, however, seems to indicate that secondary radiation therapy (RT) does not negatively affect urinary continence.

Compensation is a big reason that specialists are joining the ranks of the hospital employed. But there are many factors beyond compensation to consider in hospital employment.

Initial success rates of abdominal sacrocolpopexy for pelvic organ prolapse decline over the long term, according to a recently published multicenter study.

A new study has confirmed that a genetic test that measures cell cycle progression (CCP) can be a useful tool for predicting which patients will have prostate cancer recurrence, especially when combined with existing information from laboratory and pathology tests.

The FDA has approved radium Ra 223 dichloride (Xofigo) injection for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases, and no known visceral metastatic disease.

Older prostate cancer patients with three or more underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by UCLA urologists.

The push to reform Medicare’s sustainable growth rate (SGR) formula continues in Washington, with support for SGR repeal coming from leading House of Representatives committees.

Saying it’s time to take the guesswork out of buying a legitimate drug online and combat counterfeiters, Pfizer has launched a prescription-fulfillment website for the phosphodiesterase type-5 inhibitor sildenafil citrate (Viagra).

The AUA and the American Society for Radiation Oncology (ASTRO) have released a joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.

A new genomic test for prostate cancer appears to help predict whether men are more likely to harbor an aggressive form of the disease, report researchers from the University of California, San Francisco.

Urologists’ compensation for on call coverage compares favorably with that of some other specialties and exceeds family physicians’ compensation, according to a survey that shows a wide variation in on call compensation by specialty.

Pediatric urology surgeon David Roth, MD, has been named the chief of urology at Texas Children’s Hospital in Houston.

Data from a recent multicenter study provide new evidence that the beta-3 adrenoceptor agonist mirabegron (Myrbetriq) appears to be a viable alternative in patients with overactive bladder (OAB) who are poor responders to antimuscarinic agents or intolerant of their adverse events.